Добірка наукової літератури з теми "Aminobisphosphonate"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Aminobisphosphonate".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Aminobisphosphonate"
Das, Hiranmoy, Lisheng Wang, Arati Kamath та Jack F. Bukowski. "Vγ2Vδ2 T-cell receptor–mediated recognition of aminobisphosphonates". Blood 98, № 5 (1 вересня 2001): 1616–18. http://dx.doi.org/10.1182/blood.v98.5.1616.
Повний текст джерелаEndo, Yasuo, Masahiko Shibazaki, Kouji Yamaguchi, Masanori Nakamura, and Hiroshi Kosugi. "Inhibition of inflammatory actions of aminobisphosphonates by dichloromethylene bisphosphonate, a non-aminobisphosphonate." British Journal of Pharmacology 126, no. 4 (February 1999): 903–10. http://dx.doi.org/10.1038/sj.bjp.0702367.
Повний текст джерелаKantoci, Darko, J. Kane Denike, and William J. Wechter. "Synthesis of Aminobisphosphonate." Synthetic Communications 26, no. 10 (May 1996): 2037–43. http://dx.doi.org/10.1080/00397919608003560.
Повний текст джерелаKANTOCI, D., J. K. DENIKE, and W. J. WECHTER. "ChemInform Abstract: Synthesis of Aminobisphosphonate." ChemInform 27, no. 34 (August 5, 2010): no. http://dx.doi.org/10.1002/chin.199634177.
Повний текст джерелаCairo, Cristiana, Bertrand Sagnia, Giulia Cappelli, Rose Leke, Robert Leke, Vittorio Colizzi та C. Pauza. "Repertoire selection and effector functions of neonatal γδ T cells (85.12)". Journal of Immunology 184, № 1_Supplement (1 квітня 2010): 85.12. http://dx.doi.org/10.4049/jimmunol.184.supp.85.12.
Повний текст джерелаKuźnik, Anna, Dominika Kozicka, Wioleta Hawranek, Karolina Socha та Karol Erfurt. "One-Pot and Catalyst-Free Transformation of N-Protected 1-Amino-1-Ethoxyalkylphosphonates into Bisphosphonic Analogs of Protein and Non-Protein α-Amino Acids". Molecules 27, № 11 (2 червня 2022): 3571. http://dx.doi.org/10.3390/molecules27113571.
Повний текст джерелаMeraviglia, Serena, Carmela La Mendola, Valentina Orlando, Francesco Scarpa, Giuseppe Cicero та Francesco Dieli. "Vγ9Vδ2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies". Oncology Reviews 4, № 4 (14 грудня 2011): 211. http://dx.doi.org/10.4081/oncol.2010.211.
Повний текст джерелаNAKASHIMA, Mitsuyoshi, Mitsutaka KANAMARU, and Norihiro TAKENAGA. "Phase I Study of Alendronate, a New Aminobisphosphonate." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 26, no. 2 (1995): 475–89. http://dx.doi.org/10.3999/jscpt.26.475.
Повний текст джерелаLiu, Chia-Yuan, Po-Sheng Yang, Shih-Ping Cheng, Yu-Chuen Huang, Jie-Jen Lee, Chun-Chuan Ko, Hui-Ru Shieh, and Yu-Jen Chen. "Zoledronic acid, an aminobisphosphonate, prolongs survival of skin allografts." Clinical & Investigative Medicine 35, no. 4 (August 4, 2012): 165. http://dx.doi.org/10.25011/cim.v35i4.17144.
Повний текст джерелаMoon, Myung-Sang, Ki-Tae Kwon, Chang-Won Ha, Sung-Soo Kim, Sung Sim Kim, and Hanlim Moon. "BONE HISTOLOGY OF PATIENTS WITH ALENDRONATE-MEDIATED FRACTURED BONE — A NEW ENTITY OF ATYPICAL OSTEOMALACIA." Journal of Musculoskeletal Research 17, no. 03 (September 2014): 1450011. http://dx.doi.org/10.1142/s0218957714500110.
Повний текст джерелаДисертації з теми "Aminobisphosphonate"
Daguzan, Charline. "Analyse des propriétés antivirales des lymphocytes T Vgamma9Vdelta2 humains : potentiel immuno-thérapeutique au cours des infections par le cytomégalovirus humain." Thesis, Toulouse 3, 2015. http://www.theses.fr/2015TOU30241/document.
Повний текст джерелаAminobisphosphonates (ABP) treatment of cells induces intracellular accumulation of molecules (IPP, ApppI) which stimulate human Vy9Vd2 T cells. Although these lymphocytes do not appear naturally activated during human cytomegalovirus (HCMV) infection, the laboratory demonstrated a synergistic effect of HCMV and ABP on Vy9Vd2 T cell activation. My PhD thesis aimed to analyze the mechanism of this synergy and evaluate the immunotherapeutic potential of ABP in the context of HCMV infection. After ABP treatment of cells in vitro, we showed that HCMV-infected cells strongly activated Vy9Vd2 T cells. ABP-treated fibroblasts activate Vy9Vd2 T cells to produce IFN-y but not TNF. The HCMV infection of these fibroblasts stimulates TNF secretion and an increased production of IFN-y, indicating that Vy9Vd2 cells can sense HCMV infection. Increased cytokine production was observed with Vy9Vd2 T cell lines and "fresh" Vy9Vd2 directly isolated of blood. Moreover, Vy9Vd2 T cell activation was observed with most HCMV strains (laboratory strains or clinical isolates) and different HCMV-permissive cells. We also showed that HCMV infection induces an overproduction of IPP and ApppI in ABP-treated cells, which explains in part the increased cytokine production by Vy9Vd2 T cells. At last, we demonstrated the capacity of Vy9Vd2 T cells to limit viral replication and production after ABP treatment while preserving uninfected cells. Our experiments indicate that this antiviral activity involves IFN-y and TNF secretion by Vy9Vd2 T cells but not their cytotoxicity activity. Consequently, my work provides a proof of concept of the therapeutic potential of ABP in the context of HCMV infection
Gundermann, Stefan [Verfasser], та Volker [Gutachter] Kunzmann. "Untersuchungen zur natürlichen und Aminobisphosphonat-induzierten antileukämischen Aktivität von humanen allogenen Vγ9Vδ2 T-Zellen gegenüber akuter myeloischer Leukämie / Stefan Gundermann. Gutachter: Volker Kunzmann". Würzburg : Universität Würzburg, 2014. http://d-nb.info/1102828513/34.
Повний текст джерелаGebhard, Harry Heinz [Verfasser]. "Effekt von selektivem Cyclooxygenase 2-Inhibitor Celecoxib und Aminobisphosphonat Ibandronat auf die Entzündungsreaktion und die synoviale Mikrozirkulation in der Antigen-induzierten Arthritis der Maus / Harry Heinz Gebhard." München : Verlag Dr. Hut, 2019. http://d-nb.info/1181515483/34.
Повний текст джерелаZysk, Aneta. "Adoptive transfer of ex vivo expanded gamma delta T cells targeting osteolytic cancer in the bone." Thesis, 2017. http://hdl.handle.net/2440/119272.
Повний текст джерелаThesis (Ph.D.) -- University of Adelaide, Adelaide Medical School, 2017
Gundermann, Stefan. "Untersuchungen zur natürlichen und Aminobisphosphonat-induzierten antileukämischen Aktivität von humanen allogenen Vγ9Vδ2 T-Zellen gegenüber akuter myeloischer Leukämie". Doctoral thesis, 2014. https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-105425.
Повний текст джерелаAllogeneic γδ T cells are attractive candidates for immunotherapy of hematological malignancies due to their intrinsic ability to provide MHC-unrestricted antitumor activity without inducing graft-versus-host disease (GvHD). The present thesis evaluated the antileukemic capacity of allogeneic γδ T cells against primary acute myeloid leukemia (AML) in order to determine clinical factors that might predict the susceptibility of AML cells to γδ T cells. Leukemic blasts were obtained from 19 newly diagnosed AML patients. In vitro alloreactivity of Vγ9Vδ2 T cells lines derived from TCR αβ depleted leukapheresis products was evaluated by flow-cytometer based cytotoxicity assays. Marked differences of γδ T cell mediated cytotoxicity against AML blasts. 7 of 19 AML samples (37%) were intrinsically susceptible to allogeneic γδ T cells. Pretreatment of primary AML blasts with nitrogen-containing bisphosphonates (NBP) significantly induced (p<0.01) γδ T cell cytotoxicity in a dose-dependent manner in 32% of AML samples. The remaining 31% AML samples were consistently refractory to γδ T cell immunotargeting. ULBP1 surface expression and myelo-monocytic differentiation of AML cells correlated with innate and NBP-induced killing of AML cells by allogeneic γδ T cells, whereas KIR-ligand mismatch status, cytogenetic risk profiles and response to induction chemotherapy showed no correlation with the susceptibility of primary AML blast to γδ T cells. This study identifies relevant subsets of AML as attractive targets for upcoming γδ T cell based adoptive immunotherapies
Частини книг з теми "Aminobisphosphonate"
"Aminobisphosphonate." In Encyclopedia of Pain, 116. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-28753-4_200098.
Повний текст джерелаТези доповідей конференцій з теми "Aminobisphosphonate"
Zakeri, Nekisa, Andrew Hall, Leo Swadling, Laura J. Pallett, Nathalie M. Schmidt, Mariana O. Diniz, Stephanie Kucykowicz, et al. "O06 Aminobisphosphonates enhance liver-resident gamma delta T cells for efficient targeting of hepatocellular carcinoma." In Abstracts of the British Association for the Study of the Liver Annual Meeting, 22–24 November 2021. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2021. http://dx.doi.org/10.1136/gutjnl-2021-basl.6.
Повний текст джерелаGiollo, A., F. Bettili, F. Ghellere, O. Viapiana, L. Idolazzi, D. Gatti, and M. Rossini. "THU0434 Predictors of long-term glucocorticoid therapy in polymyalgia rheumatica: discontinuation is more common for patients treated with aminobisphosphonates." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3055.
Повний текст джерела